Skip to main content
. 2014 Oct 28;7(2):157–164. doi: 10.1007/s12402-014-0154-x

Table 3.

Effect duration [h] of the preceding MPH medication and Ritalin® LA, as assessed by parents at the baseline and the final visit, respectively

Preceding MPH Ritalin® LA P*
All changing patients 6.2 ± 2.0 (147) 7.3 ± 1.4 (224) <0.001
Subgroups changing for
 Poor effectiveness 6.1 ± 2.0 (87) 7.5 ± 1.4 (103) <0.001
 Other reasons 6.5 ± 2.0 (60) 7.0 ± 1.4 (119) 0.037
 P** 0.139 0.023

Values are mean ± standard deviation (number of patients with data)

* Wilcoxon; ** Mann–Whitney test